BioCentury
ARTICLE | Clinical News

Herpes zoster vaccine: Phase III started

September 6, 2010 7:00 AM UTC

GSK began the double-blind, placebo-controlled, international Phase III Zoster-006 trial to evaluate intramuscular herpes zoster vaccine in 27,400 patients ages 50 and older. The vaccine contains the ...